Literature DB >> 1982483

Glutamine synthetase inhibition prevents cerebral oedema during hyperammonemia.

H Takahashi1, R C Koehler, S W Brusilow, R J Traystman.   

Abstract

The relationship between cerebral oedema and cerebral glutamine accumulation was investigated during acute hyperammonemia in anesthetized rats. Six hours of ammonium acetate infusion resulted in an increase in cortical glutamine concentration and a decrease in specific gravity. Pretreatment with methionine sulfoximine inhibited glutamine synthetase, prevented the increase in glutamine during hyperammonemia, and prevented the decrease in specific gravity. We conclude that the increase in brain water content is linked to the glutamine accumulation derived from the detoxification of ammonia by glutamine synthetase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1982483     DOI: 10.1007/978-3-7091-9115-6_117

Source DB:  PubMed          Journal:  Acta Neurochir Suppl (Wien)


  5 in total

Review 1.  Oxidative stress in the pathogenesis of hepatic encephalopathy.

Authors:  M D Norenberg; A R Jayakumar; K V Rama Rao
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 2.  Brain imaging in urea cycle disorders.

Authors:  Andrea Gropman
Journal:  Mol Genet Metab       Date:  2010-02-13       Impact factor: 4.797

Review 3.  Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy.

Authors:  Saul W Brusilow; Raymond C Koehler; Richard J Traystman; Arthur J L Cooper
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

Review 4.  Protein tyrosine nitration in hyperammonemia and hepatic encephalopathy.

Authors:  Dieter Häussinger; Boris Görg; Roland Reinehr; Freimut Schliess
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

5.  Changes in brain ECF amino acids in rats with experimentally induced hyperammonemia.

Authors:  K Suzuki; N Matsuo; T Moriguchi; N Takeyama; Y Kitazawa; T Tanaka
Journal:  Metab Brain Dis       Date:  1992-06       Impact factor: 3.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.